These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28478159)

  • 21. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural development of self nano emulsifying drug delivery systems (SNEDDS) during in vitro lipid digestion monitored by small-angle X-ray scattering.
    Fatouros DG; Deen GR; Arleth L; Bergenstahl B; Nielsen FS; Pedersen JS; Mullertz A
    Pharm Res; 2007 Oct; 24(10):1844-53. PubMed ID: 17458683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study by (1)H NMR on the influence of some factors affecting lipid in vitro digestion.
    Nieva-Echevarría B; Goicoechea E; Manzanos MJ; Guillén MD
    Food Chem; 2016 Nov; 211():17-26. PubMed ID: 27283602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suitability of Artificial Membranes in Lipolysis-Permeation Assays of Oral Lipid-Based Formulations.
    Hedge OJ; Bergström CAS
    Pharm Res; 2020 May; 37(6):99. PubMed ID: 32435855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems.
    Pouton CW
    Eur J Pharm Sci; 2000 Oct; 11 Suppl 2():S93-8. PubMed ID: 11033431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life.
    Arnold YE; Imanidis G; Kuentz M
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1262-9. PubMed ID: 22206451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphological observations on a lipid-based drug delivery system during in vitro digestion.
    Fatouros DG; Bergenstahl B; Mullertz A
    Eur J Pharm Sci; 2007 Jun; 31(2):85-94. PubMed ID: 17418543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
    Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
    Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
    Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
    Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Nieva-Echevarría B; Goicoechea E; Manzanos MJ; Guillén MD
    Food Res Int; 2017 Jan; 91():171-182. PubMed ID: 28290321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs.
    Carrière F
    Biochimie; 2016 Jun; 125():297-305. PubMed ID: 26607242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14.
    Fernandez S; Chevrier S; Ritter N; Mahler B; Demarne F; Carrière F; Jannin V
    Pharm Res; 2009 Aug; 26(8):1901-10. PubMed ID: 19452130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the cytotoxicity and intestinal absorption of a self-emulsifying drug delivery system containing sodium taurocholate.
    Gao H; Wang M; Sun D; Sun S; Sun C; Liu J; Guan Q
    Eur J Pharm Sci; 2017 Aug; 106():212-219. PubMed ID: 28591563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation.
    Larsen AT; Ohlsson AG; Polentarutti B; Barker RA; Phillips AR; Abu-Rmaileh R; Dickinson PA; Abrahamsson B; Ostergaard J; Müllertz A
    Eur J Pharm Sci; 2013 Jan; 48(1-2):339-50. PubMed ID: 23178440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline.
    Al Shuwaili AH; Rasool BK; Abdulrasool AA
    Eur J Pharm Biopharm; 2016 May; 102():101-14. PubMed ID: 26925505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the presence of protein on lipolysis and lipid oxidation occurring during in vitro digestion of highly unsaturated oils.
    Nieva-Echevarría B; Goicoechea E; Guillén MD
    Food Chem; 2017 Nov; 235():21-33. PubMed ID: 28554628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential.
    Singh B; Khurana L; Bandyopadhyay S; Kapil R; Katare OO
    Drug Deliv; 2011 Nov; 18(8):599-612. PubMed ID: 22008038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across Permeapad
    Ilie AR; Griffin BT; Brandl M; Bauer-Brandl A; Jacobsen AC; Vertzoni M; Kuentz M; Kolakovic R; Holm R
    Eur J Pharm Sci; 2020 Sep; 152():105452. PubMed ID: 32622980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.